메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류
인문학
인문학 일반 역사학 철학 종교학 어문학 기타 인문학
사회과학
사회과학 일반 경영학 관광학 교육학 군사학 문헌정보학 법학 사회학 신문방송학 심리과학 정치외교학 지리학 행정학 경제학 무역학 인류학 기타 사회과학
자연과학
자연과학 일반 물리학 생물학 생활과학 수학·통계학 천문학 지구과학 화학 기타 자연과학
공학
공학 일반 건축공학 기계공학 산업공학 재료·에너지공학 전기전자공학 조선해양공학 화학공학 컴퓨터학 기타공학
의약학
의학 일반 간호학 수의학 약학 한의학 기초의학 임상의학 기타 의약학
농수해양학
농수해양학 일반 농학 수산학 식품과학 임학 축산학 해상운송학 기타 농수해양학
예술체육학
예술 일반 디자인 미술 미용 사진 음악학 의상 체육 공연매체예술 기타 예술체육학
복합학
학제간연구 과학기술학 뇌인지과학 기술정책 기타 복합학

ENG

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한뇌졸중학회 대한뇌졸중학회지 대한뇌졸중학회지 제17권 제2호
발행연도
2015.1
수록면
93 - 93 (1page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
MR CLEAN, ESCAPE, EXTEND-IA, SWIFT PRIME, REVASCAT, THERAPY, THRACE: we are inundated by positive trials. In this issue of the Journal of Stroke (JOS), two important review papers are published. Dr. Ding nicely summarizes these results,1 while Dr. Yan and his colleagues emphasize the advancement of devices as one of the main reasons for the successful trials.2 Their messages are clear; endovascular therapy is helpful for treating stroke patients as long as appropriate patients are selected and good devices are used by skillful interventionalists. These recent series of trials will change the landscape of the neurology world. Although countries such as Korea already have actively used endovascular therapy, the endovascular strategy will soon spread worldwide. It is expected that increasing numbers of young physicians will choose to become endovascular specialists, device companies will prosper, and endovascular societies will strengthen. Accordingly, there will be a rapid increase in the number of comprehensive stroke centers equipped with advanced imaging tools and endovascular specialists. Undoubtedly, these factors will benefit stroke patients. However, this also means that medical costs will increase dramatically. Since excellent stroke centers armed with modern imaging tools and experienced interventionalists are costly even in affluent countries, such costs are likely to unacceptable in less affluent countries. Regardless of economic conditions, the costs will skyrocket globally as populations worldwide continue to age rapidly. In reality, the cost incurred by treating and preventing cerebrovascular diseases is already a significant burden to us; therefore, we must continue investigating less costly strategies. Endovascular therapy developed as a result of the defects of intravenous (IV) tissue plasminogen activator (t-PA), which has limited efficacy in re-canalizing occluded large arteries, has a very short therapeutic time window (<4.5 hours), and is associated with hemorrhagic complications unless administered early enough. To resolve these problems, drugs have been developed that are potentially more effective and safe than IV t-PA. One candidate is desmoteplase, which unfortunately does not yet have proven benefit. Several drugs such as minocycline are now being examined to determine whether they can reduce bleeding complications when used with IV t-PA. These and other drugs under development may increase the efficacy and safety or prolong the therapeutic time window of IV thrombolysis. I suspect that they may ultimately replace endovascular therapy, a more costly and complicated way of treatment, in the future. Although I fully agree with Drs. Ding and Yan, and am one of the most excited neurologists by these positive trials, I also worry that official acceptance of endovascular therapy as a “standard treatment” might prevent the proper examination of simpler, less expensive and potentially more effective treatments. We all know that potentially efficacious thrombolytics could not be tested in the early stage of stroke simply because IV t-PA has been designated a “standard treatment.” I hope my concern is groundless, and wish that you read this issue of the JOS comfortably.

목차

등록된 정보가 없습니다.

참고문헌 (2)

참고문헌 신청
Balasubramaian A / 2015 / Evolution of endovascular therapy in acute stroke: implications of device development / J Stroke 17 : 127 ~ 137 google schola Ding D / 2015 / Endovascular mechanical thrombectomy for acute ischemic stroke: a new standard of care / J Stroke 17 : 123 ~ 126 google schola

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0